Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2874963 | The Annals of Thoracic Surgery | 2011 | 8 Pages |
Abstract
Most cT2-T3N0M0 patients have pN+ disease. Despite induction therapy, more than 50% have persistent nodal disease. Transthoracic esophagectomy is more likely to detect pN+ disease and more likely to meet criteria of adequate nodal dissection than is transhiatal esophagectomy. Therefore, the majority of patients with cT2-T3N0M0 should be considered for neoadjuvant protocols and should be treated by transthoracic resection whenever possible.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Brendon M. MD, Farooq MD, Anthony MD, Jeffrey L. MD, Paul C. MD, Subroto MD, Nasser K. MD,